Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals Codexis, Arch Pharmalabs Expand Manufacturing CollaborationChinese Firm to Supply APIs to BoehringerSiegfried Posts Higher Earnings and Flat SalesPronova Signs Intermediates DealSanofi-Aventis Buys Australian Firm Related Stories Patheon Losses ContinueDSM Invests in Probiotics StartupSuppliers Predict 2008 Market GrowthCambrex Profits Fall on Low Generic API SalesCardinal Inks Deal to Sell Contract Manufacturing Unit

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

November 14, 2007

Cambrex’s Third-Quarter Profits Rise

Chemical Week Editorial Staff

Cambrex reported a 30% hike in third-quarter operating profits, to $3.5 million, on sales up 2.3%, to $54.7 million. The figures relate solely to ongoing businesses. Cambrex sold its biotechnology and biopharmaceuticals unit to Lonza in the past year. Lower...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers